How Much Will Pfizer Pay Out in Dividends This Year?

Core Viewpoint - Pfizer, as a leading pharmaceutical company, is generating substantial cash flow, primarily driven by its innovative medicines and COVID-19 products, allowing it to return significant value to shareholders through dividends and potential future increases in payouts [1][2]. Group 1: Dividend Payments - Pfizer announced a dividend increase to $0.42 per share, up from $0.41, indicating a commitment to returning value to shareholders [2]. - The company is expected to distribute approximately $9.52 billion in dividends this year, based on its outstanding shares of about 5.67 billion [2]. Group 2: Share Repurchase and Stock Performance - Pfizer's existing share repurchase authorization is $3.3 billion; however, the company does not plan to repurchase shares this year, which may impact the stock's performance [2]. - The stock currently offers a yield of 5.8%, making it attractive for investors seeking income [3]. Group 3: Revenue and Growth Potential - Despite a decline in total sales, excluding COVID-19 products and currency fluctuations, Pfizer's first-quarter revenue increased by 11% year over year, indicating underlying growth potential [3]. - With the worst impacts of COVID-19 behind, Pfizer's profitability is expected to improve significantly over the coming years, making it a favorable addition to diversified investment portfolios [3].